IT vs LCTX · P/E 16, rev $6.27B vs rev $9.5M
Gartner Inc (IT) versus Lineage Cell Therapeutics Inc (LCTX) — a side-by-side from cached financials, not a winner call.
Gartner Inc (IT) is a information technology services company listed on US.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Latest reported LCTX revenue for 2024-12-31 was $9.5M. Net income was -$18.6M. Revenue was up 354.9% from 2023-12-31 to 2024-12-31. LCTX currently screens at market cap $213.6M.
IT currently screens at market cap $11.03B and trailing P/E 16.3. LCTX currently screens at market cap $213.6M.
Not investment advice. Open the IT and LCTX stock pages for the full models.
Not investment advice.